Cebu Pacific Back To Full Year Profit After Pandemic Losses

Cebu Pacific soars to new heights with Php 90.6 billion in revenue for 2023, marking a 60% increase from the previous year!

FDA DG Assists Small Businesses With BBMSME Program, Joins First Lady in Tuguegarao

Food and Drug Administration Director General Dr. Samuel Zacate partners with Tuguegarao Mayor to empower local entrepreneurs through Bigyan-Halaga, Bangon Micro, Medium and Small Enterprises program.

Tala’s Iona Inigo-Mayo Shares Its Empowerment On The Organization And Its Customers

Gender-inclusive workplaces drive success! Tala empowers women, fostering leadership & financial independence, transforming lives and communities globally.

HONOR PH Introduces HONOR X7b, Another High-Quality Phone Without Breaking Your Wallet

HONOR Philippines locally debuts the durable, budget-friendly HONOR X7b, boasting impressive features like extended battery life and superb display.

PH’s Clinical Trials For Avigan Face Delays

0

PH’s Clinical Trials For Avigan Face Delays

0

How do you feel about this story?

Like
Love
Haha
Wow
Sad
Angry

The Philippines’ clinical trials for Japanese anti-flu drug Avigan, a potential treatment against coronavirus disease 2019 (Covid-19), are yet to start due to ethics review delays, a health official said Wednesday.

“Nagkakaroon po tayo ng (We’re having) delays on the ethics review among the different identified hospitals included in the trial,” Department of Health (DOH) Undersecretary Maria Rosario Vergeire said in a virtual media forum.

Vergeire reported that the ethics review of Dr. Jose N Rodriguez Memorial Hospital, Quirino Memorial Medical Center, and Sta Ana Hospital are not yet final.

“As for the Philippine General Hospital, the MOA (memorandum of Agreement) is under legal review of UP Manila but they already have an approved ethics review, so we’re just waiting for the three hospitals,” she said in a mix of Filipino and English.

On Aug. 6, the DOH received Avigan supply from Tokyo allotted for 100 patients who are part of the clinical trial which was supposed to start on Sept. 1.

“We also have to finalize the clinical trial agreement. We already have all the input coming from our legal offices and these will be signed by Secretary (Francisco) Duque,” Vergeire said. (PNA)